Title: New Frontiers in Pathology GU case presentation
1New Frontiers in PathologyGU case presentation
- Rajal B. Shah, M.D.
- Associate Professor - Pathology and Urology
2Case 13
- A 65 year-old white American male with serum PSA
of 4 ng/ml, underwent extended 12 core biopsies
3(No Transcript)
4(No Transcript)
534ßE12 p63
6P504S
7P504S
8Summary of atypical findings
- Disorganized growth pattern
- Presence of some round and poorly formed small
glands - Micro nucleoli
- Lack of basal cell staining in some glands
- AMACR reactivity
9Diagnosis
- Benign prostate parenchyma with focus of partial
atrophy
10Diagnosis of Limited Cancer in Prostate Biopsy
Critical Issues
- Recognize cancer and avoid under-diagnosis (false
negative) - Recognize benign mimics and avoid over-diagnosis
(false positive)
11Mimics of Prostate Cancer
Pattern 1 Small glandular growth pattern
Pattern 2 Cribriform/large growth pattern
Pattern 3 Fused gland/solid growth pattern
12Pattern 1-Small gland mimics
- Seminal vesicle/ejaculatory duct epithelium
- Cowpers glands
- Verumontenum hyperplasia
- Crowding of small glands
- Mucinous metaplasia
- Mesonephric gland hyperplasia
- Post atrophic hyperplasia/atrophy
- Partial atrophy
- Adenosis
- Radiation atypia
- Nephrogenic adenoma
- Basal cell hyperplasia
13PA Among the most common reasons for second
opinion
Herawi M et al, AJSP, 2005
14Partial atrophy (PA) - Background
- Experts have utiized various terms to describe
partial atrophy - Some have used the term post atrophic hyperplasia
(PAH) to describe similar lesions - (Amin MB et al, 1999, Srigley JR et al, 2004)
- Recently PA and PAH recognized as a distinct
types of focal atrophy in the Working Group
Classification of Focal Prostate Atrophy Lesions
(De Marzo et al, 2006)
15Partial atrophy - Significance
- Potential for confusion with prostatic
adenocarcinoma (PCa) - Among the most common reasons for second opinion
in a consultation practice (Herawi et al, 2005) - Potential immunohistochemical (basal cell markers
and P504S (monoclonal antibody to AMACR)) overlap
with PCa - Association with inflammation and proliferation
found in certain forms of atrophy such as post
atrophic hyperplasia (Ruska et al, 1998 De Marzo
et al, 1999 Shah R et al, 2001)
16AJSP, 32(1), 2008
- Architectural indices
- Gland size
- Gland shape
- Circumscription
- Stromal characteristics
- Associated completely atrophic glands within the
focus - Luminal secretions
- Inflammation
- Cytological indices
- Character of cytoplasm
- Nuclear size in relation to benign glands
- Micronucleoli (visible only at 40x) and
macronucleoli (visible easily at 10X)
17AJSP, 32(1), 2008
- Basal cell marker cocktail(34ßE12 p63)
- Completely positive
- Patchy positive
- Completely negative
- P504S - Rabbit monoclonal antibody to AMACR (Zeta
corporation, Sierra Madre, CA ) - Negative
- Weak
- Moderate-to-strong
- (Expression evaluated in relation to benign
glands)
18Study design - Proliferation status
- Ki-67 (MIB-1 clone) immunohistochemistry
- Quantitative analysis by ChromaVision ACIS
- Measurement of stain intensity of
- PA foci compared with benign glands (range
0-225, 0-100) - Manual delineation of foci
19Results - Morphology (architectural features)
N73 foci
20Circumscribed focus with stellate star shaped
glands
21Disorganized poorly formed round glands
22Results - Morphology (architectural features)
FEATURES
CASES
23Complete dark atrophic glands within the focus
24Results - Morphology (cytologic features)
FEATURES
CASES
25Micro nucleoli visible at high power
26- Other benign conditions known to contain
nucleoli - gt Basal cell hyperplasia
- gt Post atrophic hyperplasia
- gt Adenosis
- gt Radiation atypia
- gt Benign glands associated with
inflammation -
27Clear cytoplasm similar to adjacent benign
glands, placed laterally to Nuclei giving them
partially atrophic look
28Results IHC Basal cell markers cocktail 34ßE12
p63
29(No Transcript)
30(No Transcript)
31(No Transcript)
32Other lesions with patchy/negative basal cell
reactions
- PIN
- Adenosis
- Lack of basal cell staining in few atypical
glands is not necessarily diagnostic of cancer
33Results IHC P504S
34Comparison with published literature
- AMACR results
- 79 (15/19 cases) (Herawi et al, 2005)
- Series consisting of selected consultation cases
with AMACR staining performed at multiple
institutions - 31 (38/122 foci) (Adley et al, 2006)
- Hospital based series, AMACR staining using the
triple antibody (P504S CK 903 p63)
35AMACR-specificity issues
PIN Prostatic intraepithelial neoplasia, NA
Nephrogenic adenoma NS Not studied
36Results - Basal cell markers and P504S antibody
as a panel
37 Results - Proliferation status
- N54 foci
- Mean proliferative indices
- PA foci5.5 (range 0-30)
- Benign glands5.6 (range 0-31)
- P0.97 (paired t-test)
38Summary - Features that potentially mimic
prostate cancer
- Morphology
- Disorganized growth pattern
- Small, round, poorly-formed glands
- Visible nucleoli
- Immunohistochemistry
- Very patchy/negative staining for basal cells
- Possible AMACR positivity
39Summary - Reliable morphologic features of PA
- Stellate/undulated gland lumina
- Pale cytoplasm similar to adjacent benign glands
- Presence of completely atrophic glands within the
focus - Lack of nuclear enlargement or macronucleoli
40Morphological low-power comparison of PAH and PA
PAH
PA
PAH post atrophic hyperplasia, PA partial
atrophy
41So where to draw a line between partial atrophy
and atypia/cancer?
- Infiltrative glands
- Amphophilic cytoplasm
- Macronucleoli
- Presence of blue mucin
- Lack of basal cell markers and/or AMACR
positivity with any of the above features
42Architectural/cytological features not specific
but suggest the benign diagnosis
43Architecture Lobular/circumscribed growth
44Pseudo infiltrative appearance patch like
growth pattern
45Benign glands as reference Similar cytoplasmic
character
Benign gland
46Cellular spindle cell stroma
BCH Adenosis Sclerosing adenosis
47Complete atrophy BCH
Nuclei occupy full cell height
48SV Radiation atypia
Random cytological atypia
49Radiation atypia
Random cytological atypia, smudgy nuclei,
prominent nucleoli, cytoplasmic vacuolization
50Conclusions
- A systemic approach using constellation of
architectural and cytological features necessary
to work up atypical small glandular
proliferations - Diagnosis relies on constellation of features
- Use markers to support your impression, use them
as a panel - An expert second opinion can help reduce atypia
rate
51Thank You